Literature DB >> 33004535

Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey.

Lisa K Stamp1, William Taylor2, Angelo Gaffo.   

Abstract

Entities:  

Year:  2020        PMID： 33004535     DOI： 10.3899/jrheum.200347

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.

Authors:  Mark D Russell; Andrew I Rutherford; Benjamin Ellis; Sam Norton; Abdel Douiri; Martin C Gulliford; Andrew P Cope; James B Galloway
Journal:  Lancet Reg Health Eur       Date:  2022-05-25

Review 2.  Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights.

Authors:  Yongsheng Mei; Bingzi Dong; Zhuang Geng; Lili Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

Review 3.  Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities.

Authors:  Lisa K Stamp; Hamish Farquhar; Huai Leng Pisaniello; Ana B Vargas-Santos; Mark Fisher; David B Mount; Hyon K Choi; Robert Terkeltaub; Catherine L Hill; Angelo L Gaffo
Journal:  Nat Rev Rheumatol       Date:  2021-07-30       Impact factor: 20.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.